InsiderTrades.com logo

VNDA Insider Trading

Insider Ownership Percentage: 8.90%
Insider Buying (Last 12 Months): $270,800.00
Insider Selling (Last 12 Months): $32,130.00

Vanda Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Vanda Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Vanda Pharmaceuticals Share Price & Price History

Current Price: $8.17
Price Change: ▲ Price Increase of +0.02 (0.25%)
As of 02/24/2026 05:00 PM ET

This chart shows the closing price history over time for VNDA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Vanda Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/13/2025Stephen Ray MitchellDirectorSell7,000$4.59$32,130.0097,082View SEC Filing Icon  
5/21/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.40$44,000.002,325,731View SEC Filing Icon  
5/16/2025Mihael Hristos PolymeropoulosCEOBuy20,000$4.22$84,400.002,315,731View SEC Filing Icon  
3/5/2025Mihael Hristos PolymeropoulosCEOBuy10,000$5.02$50,200.002,285,731View SEC Filing Icon  
2/28/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.76$47,600.002,361,730View SEC Filing Icon  
2/25/2025Mihael Hristos PolymeropoulosCEOBuy10,000$4.46$44,600.002,331,730View SEC Filing Icon  
2/21/2025Kevin Patrick MoranCFOBuy2,000$4.39$8,780.00355,763View SEC Filing Icon  
11/14/2024Stephen Ray MitchellDirectorSell5,000$5.17$25,850.0044,857View SEC Filing Icon  
7/29/2024Kevin Patrick MoranCFOSell2,251$5.92$13,325.92228,763View SEC Filing Icon  
8/21/2023Joakim WijkstromCMOSell3,724$5.84$21,748.16113,816View SEC Filing Icon  
8/10/2023Stephen Ray MitchellDirectorSell6,500$6.05$39,325.0029,328View SEC Filing Icon  
7/28/2023Kevin Patrick MoranCFOSell2,212$6.30$13,935.60120,714View SEC Filing Icon  
6/15/2023Kevin Patrick MoranCFOSell16,000$6.29$100,640.00122,926View SEC Filing Icon  
6/13/2023Timothy WilliamsSVPSell14,600$6.56$95,776.0088,913View SEC Filing Icon  
3/2/2023Joakim WijkstromCMOSell7,720$6.23$48,095.60121,653View SEC Filing Icon  
3/2/2023Kevin Patrick MoranCFOSell7,966$6.26$49,867.16144,894View SEC Filing Icon  
3/2/2023Mihael Hristos PolymeropoulosCEOSell22,426$6.23$139,713.981,499,440View SEC Filing Icon  
3/2/2023Timothy WilliamsSVPSell8,437$6.24$52,646.88111,814View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Vanda Pharmaceuticals (NASDAQ:VNDA)

88.14% of Vanda Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VNDA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Vanda Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/19/2026Invesco Ltd.122,995$1.09M0.0%-12.9%0.208%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV43,829$0.39M0.0%+51.2%0.074%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP178,851$1.58M0.0%-5.4%0.303%Search for SEC Filing on Google Icon
2/18/2026Susquehanna Portfolio Strategies LLC150,427$1.33M0.0%+35.1%0.254%Search for SEC Filing on Google Icon
2/18/2026Tudor Investment Corp ET AL88,588$0.78M0.0%-31.1%0.150%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC1,679,013$14.81M0.0%-47.5%2.840%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.68,178$0.60M0.0%N/A0.115%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC79,600$0.70M0.0%-36.7%0.135%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC59,107$0.52M0.0%N/A0.100%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC627,006$5.53M0.0%-6.2%1.061%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC10,651$94K0.0%N/A0.018%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP204,491$1.80M0.0%N/A0.346%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC473,800$4.18M0.1%+243.3%0.802%Search for SEC Filing on Google Icon
2/17/2026Kotler Kevin100,000$0.88M0.2%N/A0.169%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD35,283$0.31M0.0%+20.6%0.060%Search for SEC Filing on Google Icon
2/17/2026Public Employees Retirement System of Ohio48,769$0.43M0.0%+129.8%0.083%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.62,253$0.55M0.0%+858.5%0.105%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board150,542$1.33M0.0%+47.0%0.255%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.23,060$0.20M0.0%N/A0.039%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC135,839$1.20M0.0%+18.6%0.230%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.118,987$1.05M0.0%+3.4%0.201%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC191,036$1.69M0.0%-14.2%0.323%Search for SEC Filing on Google Icon
2/13/2026Sassicaia Capital Advisers LLC14,700$0.13M0.3%N/A0.025%Search for SEC Filing on Google Icon
2/13/2026Jacobs Levy Equity Management Inc.708,428$6.25M0.0%+552.3%1.199%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.500,515$4.42M0.0%+2.4%0.847%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,263,539$11.14M0.0%-0.6%2.138%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC31,070$0.27M0.0%-40.1%0.053%Search for SEC Filing on Google Icon
2/13/2026Martingale Asset Management L P33,114$0.29M0.0%+87.3%0.056%Search for SEC Filing on Google Icon
2/13/2026Caitong International Asset Management Co. Ltd10,389$92K0.3%+3,010.5%0.018%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN68,743$0.61M0.0%+40.3%0.116%Search for SEC Filing on Google Icon
2/12/2026Empire Financial Management Company LLC1,108,245$9.78M2.1%+46.2%1.875%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC24,410$0.22M0.0%-24.4%0.041%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC3,380,961$29.82M0.0%-2.8%5.721%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP2,118,428$18.68M0.0%-17.4%3.584%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.554,427$4.89M0.0%-18.7%0.938%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.48,522$0.43M0.0%+73.8%0.082%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC291,473$2.57M0.0%+70.4%0.493%Search for SEC Filing on Google Icon
2/11/2026Janney Montgomery Scott LLC175,541$1.55M0.0%N/A0.297%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.396,017$3.49M0.0%+98.1%0.670%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming15,414$0.14M0.0%-43.5%0.026%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.408,342$3.60M0.0%+20.2%0.691%Search for SEC Filing on Google Icon
2/10/2026AXQ Capital LP26,557$0.23M0.1%N/A0.045%Search for SEC Filing on Google Icon
2/10/2026Monaco Asset Management SAM196,286$1.73M0.3%-20.8%0.332%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC23,252$0.21M0.0%-10.0%0.039%Search for SEC Filing on Google Icon
2/6/2026GSA Capital Partners LLP148,757$1.31M0.1%-53.3%0.252%Search for SEC Filing on Google Icon
2/2/2026AIGH Capital Management LLC1,998,431$17.63M4.3%N/A3.381%Search for SEC Filing on Google Icon
1/30/2026Torren Management LLC2,779$25K0.0%N/A0.005%Search for SEC Filing on Google Icon
1/29/2026Inscription Capital LLC63,878$0.56M0.1%+293.5%0.108%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH20,000$0.18M0.0%-88.9%0.034%Search for SEC Filing on Google Icon
1/26/2026CWM LLC26,979$0.24M0.0%-18.6%0.046%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA103,446$0.91M0.0%-25.5%0.175%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC10,807$95K0.0%N/A0.018%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC23,413$0.19M0.0%+33.8%0.040%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.199,893$1M0.0%+16.5%0.338%Search for SEC Filing on Google Icon
1/1/2026Tudor Investment Corp ET AL128,636$0.64M0.0%-6.3%0.218%Search for SEC Filing on Google Icon
12/9/2025Tudor Investment Corp ET AL128,636$0.64M0.0%-6.3%0.218%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.108,610$0.54M0.0%-34.6%0.184%Search for SEC Filing on Google Icon
11/17/2025Krensavage Asset Management LLC1,180,388$5.89M2.5%+15.2%1.997%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC57,037$0.29M0.2%N/A0.097%Search for SEC Filing on Google Icon
11/17/2025Susquehanna Fundamental Investments LLC15,137$76K0.0%-36.2%0.026%Search for SEC Filing on Google Icon
11/17/2025Quarry LP10,702$53K0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd179,252$0.89M0.0%N/A0.303%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio21,222$0.11M0.0%-35.5%0.036%Search for SEC Filing on Google Icon
11/17/2025Nomura Holdings Inc.30,487$0.15M0.0%-23.9%0.052%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV28,993$0.15M0.0%N/A0.049%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.26,138$0.13M0.0%-14.3%0.044%Search for SEC Filing on Google Icon
11/17/2025Lido Advisors LLC10,100$50K0.0%-21.6%0.017%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE106,436$0.53M0.0%-28.8%0.180%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC14,446$72K0.0%N/A0.024%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC34,934$0.17M0.0%N/A0.059%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.29,492$0.15M0.0%-57.1%0.050%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP662,305$3.31M0.0%+25.7%1.121%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC114,554$0.57M0.0%-25.3%0.194%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG126,116$0.63M0.0%+80.6%0.213%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets65,535$0.33M0.0%+629.9%0.111%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.6,495$32K0.0%+456.6%0.011%Search for SEC Filing on Google Icon
11/12/2025Dimensional Fund Advisors LP2,563,969$12.79M0.0%-0.8%4.339%Search for SEC Filing on Google Icon
11/10/2025Monaco Asset Management SAM247,805$1.24M0.1%-18.8%0.419%Search for SEC Filing on Google Icon
11/7/2025Readystate Asset Management LP27,610$0.14M0.0%N/A0.047%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP318,799$1.59M0.1%-16.6%0.539%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,587,139$17.90M0.0%+0.4%6.070%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.199,893$1M0.0%+16.5%0.338%Search for SEC Filing on Google Icon
11/5/2025Alps Advisors Inc.27,925$0.14M0.0%-12.1%0.047%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC22,493$0.11M0.0%+30.3%0.038%Search for SEC Filing on Google Icon
11/4/2025State of Wyoming27,301$0.14M0.0%N/A0.046%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.681,836$3.40M0.0%-6.4%1.154%Search for SEC Filing on Google Icon
10/29/2025Inscription Capital LLC16,232$81K0.0%N/A0.027%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC17,500$93K0.0%N/A0.030%Search for SEC Filing on Google Icon
10/15/2025CWM LLC33,146$0.17M0.0%+254.2%0.056%Search for SEC Filing on Google Icon
10/14/2025Profit Investment Management LLC186,400$0.93M1.2%-43.5%0.315%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC10,899$54K0.0%-33.5%0.018%Search for SEC Filing on Google Icon
8/27/2025Squarepoint Ops LLC153,345$0.72M0.0%+96.5%0.260%Search for SEC Filing on Google Icon
8/15/2025Krensavage Asset Management LLC1,024,883$4.84M2.6%+35.9%1.734%Search for SEC Filing on Google Icon
8/15/2025Engineers Gate Manager LP15,806$75K0.0%N/A0.027%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets8,979$42K0.0%-72.1%0.015%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE149,471$0.71M0.0%+23.0%0.253%Search for SEC Filing on Google Icon
8/15/2025Ameriprise Financial Inc.68,699$0.32M0.0%-53.5%0.116%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC79,107$0.37M0.0%+6.1%0.134%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.30,495$0.14M0.0%-10.5%0.052%Search for SEC Filing on Google Icon
8/14/2025Sei Investments Co.190,261$0.90M0.0%-40.6%0.322%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Vanda Pharmaceuticals logo
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Read More on Vanda Pharmaceuticals

Today's Range

Now: $8.17
Low: $7.72
High: $8.55

50 Day Range

MA: $7.35
Low: $5.76
High: $8.82

52 Week Range

Now: $8.17
Low: $3.81
High: $9.60

Volume

7,528,924 shs

Average Volume

2,990,094 shs

Market Capitalization

$482.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.62

Who are the company insiders with the largest holdings of Vanda Pharmaceuticals?

Vanda Pharmaceuticals' top insider investors include:
  1. Mihael Hristos Polymeropoulos (CEO)
  2. Kevin Patrick Moran (CFO)
  3. Stephen Ray Mitchell (Director)
Learn More about top insider investors at Vanda Pharmaceuticals.

Who are the major institutional investors of Vanda Pharmaceuticals?

Vanda Pharmaceuticals' top institutional shareholders include:
  1. Renaissance Technologies LLC — 5.72%
  2. Dimensional Fund Advisors LP — 3.58%
  3. AIGH Capital Management LLC — 3.38%
  4. Millennium Management LLC — 2.84%
  5. State Street Corp — 2.14%
  6. Empire Financial Management Company LLC — 1.88%
Learn More about top institutional investors of Vanda Pharmaceuticals stock.

Which major investors are selling Vanda Pharmaceuticals stock?

Within the previous quarter, VNDA stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Dimensional Fund Advisors LP
  3. GSA Capital Partners LLP
  4. Universal Beteiligungs und Servicegesellschaft mbH
  5. Federated Hermes Inc.
  6. Simplex Trading LLC
  7. Renaissance Technologies LLC
  8. Monaco Asset Management SAM

Which major investors are buying Vanda Pharmaceuticals stock?

In the last quarter, VNDA stock was bought by institutional investors including:
  1. AIGH Capital Management LLC
  2. Jacobs Levy Equity Management Inc.
  3. Empire Financial Management Company LLC
  4. Jump Financial LLC
  5. Trexquant Investment LP
  6. JPMorgan Chase & Co.
  7. Janney Montgomery Scott LLC
  8. Nuveen LLC
Within the last year, these company insiders have bought Vanda Pharmaceuticals stock:
  1. Mihael Hristos Polymeropoulos (CEO)
  2. Kevin Patrick Moran (CFO)
Learn More investors buying Vanda Pharmaceuticals stock.